AI Tools FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive ImpairmentBy AdminBitOctober 20, 20260 The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
